SCHEMBL3370741

SCHEMBL3370741

COc1c(O)ccc(C(=O)O)c1CCCc1c(C(=O)O)ccc(O)c1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.47
MAPT P10636 1/20 0.47
CSNK2A1 P68400 1/20 0.41
SELL P14151 1/20 0.40
SELP P16109 1/20 0.40
PPARA Q07869 2/20 0.39
PPARG P37231 1/20 0.39
KAT8 Q9H7Z6 2/20 0.39
ALOX5 P09917 1/20 0.38
HTT P42858 1/20 0.38
KDM4C Q9H3R0 1/20 0.37
POLB P06746 2/20 0.37
MCL1 Q07820 1/20 0.37
TPMT P51580 1/20 0.37
HSD17B10 Q99714 1/20 0.37
LCK P06239 1/20 0.37
ALDH1A1 P00352 1/20 0.37
KLKB1 P03952 1/20 0.36
CTSB P07858 1/20 0.36
MMP9 P14780 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3365334 0.97 TDP1 (0.47) TDP1MAPTCSNK2A1SELLSELP
SCHEMBL30947789 0.95 MAPT (0.46) TDP1MAPTCSNK2A1SELLSELP
SCHEMBL3366515 0.95 MAPT (0.46) TDP1MAPTCSNK2A1SELLSELP
SCHEMBL3368061 0.95 MAPT (0.46) TDP1MAPTCSNK2A1SELLSELP
SCHEMBL3369498 0.93 TDP1 (0.50) TDP1MAPTCSNK2A1SELLSELP
SCHEMBL28665839 0.92 PPARA (0.46) TDP1MAPTPPARAPPARGKAT8
SCHEMBL25231902 0.90 PPARA (0.54) PPARAPPARGKAT8ALOX5MCL1
SCHEMBL2047272 0.90 PPARA (0.54) PPARAPPARGKAT8ALOX5MCL1
SCHEMBL31558743 0.90 PPARA (0.54) PPARAPPARGKAT8ALOX5MCL1
SCHEMBL11895245 0.89 TDP1 (0.46) TDP1MAPTCSNK2A1SELLSELP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010043631-A1 DI-VANILLOYL AND TRI-VANILLOYL DERIVATIVES FOR USE IN ANTI-CANCER THERAPY UNIVERSITE LIBRE DE BRUXELLES (BE) 2010-04-22 WO claimed
WO-2010043631-A1 DI-VANILLOYL AND TRI-VANILLOYL DERIVATIVES FOR USE IN ANTI-CANCER THERAPY UNIVERSITE LIBRE DE BRUXELLES (BE) 2010-04-22 WO disclosed